| CAS No.: | 56180-94-0 |
|---|---|
| Formula: | C25H43NO18 |
| Resource: | Natural |
| Transport Package: | 25 Kg/Carton Outside and Double Food Plastic Bags |
| Specification: | 95.0%~102.0% |
| Trademark: | SOST |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Acarbose, an α-glucosidase inhibitor, is a complex oligosaccharide with a structure similar to oligosaccharide. This non-oligosaccharide "pseudooligosaccharide" can compete with oligosaccharide at the brush border of cells in the upper small intestine and reversibly bind to α-glucosidase. Various alpha glycosidase enzymes such as enzyme maltase, isomaltose, glucose, the activity of amylase and sucrase, make sugars such as starch into maltose (disaccharides), malt trisaccharide and dextrin (oligosaccharides) slow down and then broken down into glucose, sucrose into glucose and fructose at a slower pace, thus causing the intestinal absorption of glucose, It can relieve postprandial hyperglycemia and reduce blood glucose. Long-term use can reduce the concentration of fasting blood glucose and glycosylated hemoglobin.
| Product Name | Acarbose |
| Specification | 95.0%~102.0% |
| Appearance | White crystal powder |
| Mesh | 80 mesh |
| Molecular formula | C25H43NO18 |
| Molecular weight | 645.6048 |
| CAS No | 56180-94-0 |
| Flow Chart | Obtained by fermentation from Axtinoplanes sp.SN 223/29 |
| Solubility | very soluble in water, soluble in methanol, practically insoluble in methylene chloride |
Acarbose is a new oral hypoglycemic drug. Competitive inhibition of glucoside hydrolase in the intestine. Reduce the decomposition of polysaccharide and sucrose into glucose, so that the absorption of sugar slows down accordingly, so it can reduce the blood glucose after meals. Generally used alone, or in combination with other oral hypoglycemic agents, . With food and beverage, treatment of dependent or independent diabetes mellitus.
Oligosaccharides reversibly inhibited α-glycosidase activity in the brush border of small intestinal mucosa, slowly reduced the rate of digestion of complex polysaccharides and sucrose, and subsequently delayed glucose absorption. Used in diabetes.
For the treatment of diabetes mellitus
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}